Mar Mallo

10PUBLICATIONS
88CO-AUTHORS
Predictive and prognostic markersSolid tumoursMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 10, 2026
Germline landscape stratification defines distinct molecular and prognostic groups in therapy related myeloid neoplasms.

|Sep 27, 2025
A Murine Model of Glioblastoma Initiating Cells and Human Brain Organoid Xenograft for Photodynamic Therapy Testing.

Alejandra Mosteiro, Diouldé Diao, Carmen Bedia

|Feb 13, 2025
Multikinase Treatment of Glioblastoma: Evaluating the Rationale for Regorafenib.

Ana Maria Muñoz-Mármol, Bárbara Meléndez, Ainhoa Hernandez

|Feb 24, 2024
The C250T Mutation of TERTp Might Grant a Better Prognosis to Glioblastoma by Exerting Less Biological Effect on Telomeres and Chromosomes Than the C228T Mutation.

Teresa Gorria, Carme Crous, Estela Pineda

|May 19, 2023
Regions of homozygosity confer a worse prognostic impact in myelodysplastic syndrome with normal karyotype.

Mar Mallo, Heinz Tuechler, Leonor Arenillas

|Apr 14, 2022
CD34+CD19-CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies.

Clara Bueno, Susana Barrera, Alex Bataller

Pageof 2

Frequent Collaborators

5 joint publications

Estela Pineda

5 joint publications

Francesc Solé

4 joint publications

Sira Domenech

4 joint publications

Iban Aldecoa